Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028324 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03028324 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 4 participants.
The verdict
NCT03028324, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the influence of transcranial magnetic stimulation (TMS) on speech performance in individuals with primary progressive apraxia of speech.
Interventions
- DEVICE Transcranial Magnetic Stimulation (TMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-08-09 |
| Est. Completion | 2018-11-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03028324
The ClinicalTrials.gov registry entry for NCT03028324 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT03028324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03028324 about?
NCT03028324 is a clinical study titled "Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)". The purpose of this study is to assess the influence of transcranial magnetic stimulation (TMS) on speech performance in individuals with primary progressive apraxia of speech.
What is the current status of trial NCT03028324?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2017-08-09. Estimated completion is 2018-11-13.
What interventions are being tested in trial NCT03028324?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE).
Who is sponsoring clinical trial NCT03028324?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.